Brown Technology Innovations

Brown Biomedical Innovations to Impact (BBII)

Brown Biomedical Innovations to Impact (BBII) is a translational commercial development program that supports the development of biomedical technologies by helping bridge the funding gap between early-stage biomedical innovations and well-defined commercial opportunities that are attractive to industry partners and investors. ​

BBII Support

BBII support includes providing strategic, monetary, and advisory support for well-defined research projects.​

  • Funding translational research projects - BBII Pilot awards up to $100,000 for 12 months (with possibility of renewal) and Brown Innovation Fund awards up to $250,000 for two years.
  • Advising/coaching – by an independent panel of advisors with broad expertise in evaluation, investment and commercialization of biomedical technologies.
  • Partnering/managing – BBII will identify and retain consultants and contract research organizations to leverage development expertise and provide project management support to ensure focus and timely delivery on project milestones.
  • Exploring commercial development opportunities – As opportunities progress, BBII and Brown Technology Innovations will work through established relationships with industry, venture capital, and entrepreneurial start-up resources to find the best path for further development.

How to Apply

Brown Biomedical Innovations to Impact (BBII) is a program to support innovative proof-of-concept projects with the goal of facilitating the translation of biomedical research discoveries through partnerships with industry and startups